Apotex Inc. v. Shire LLC, 2017 FC 831 (Lisdexamfetamine*)
Proth. Tabib - 2017-09-14
Read full decision. Automatically generated summary:
This motion arises in the context of an action brought by Apotex Inc. against Shire LLC and Shire Pharma Canada ULC for a declaration of non-infringement and of invalidity of Canadian Patent No. 2,027,646, entitled “Abuse Resistant Amphetamine Compounds”.
Decision relates to:
- T-1056-16 - APOTEX INC. v. SHIRE LLC ET AL